Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Lymphoma 72Precursor Cell Lymphoblastic Leukemia-Lymphoma 66Lymphoma, Large B-Cell, Diffuse 53Lymphoma, Non-Hodgkin 33Leukemia 33Burkitt Lymphoma 33Lymphoma, Mantle-Cell 20Lymphoma, Follicular 19Recurrence 13Lymphoma, B-Cell 13Hodgkin Disease 13Neoplasms 11Lymphoma, Large-Cell, Anaplastic 11Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 10Sarcoma 9Neuroblastoma 8Multiple Myeloma 8Medulloblastoma 8Lymphoma, T-Cell, Peripheral 8Lymphoma, T-Cell 7Central Nervous System Neoplasms 7Rhabdomyosarcoma 6Leukemia, Biphenotypic, Acute 6Lymphoma, B-Cell, Marginal Zone 5Wilms Tumor 4Waldenstrom Macroglobulinemia 4Sarcoma, Ewing 4Rhabdoid Tumor 4Neuroectodermal Tumors, Primitive, Peripheral 4Lymphoma, Large-Cell, Immunoblastic 4

Interventions

Lidocaine 2Vitamin B 6 1Vitamin B 12 1Vinorelbine 1Vincristine 1Transcranial Magnetic Stimulation 1Paclitaxel 1Oxaliplatin 1Lidoderm 1Geritol 1Gabapentin 1Folfox protocol 1Drug Therapy 1Docetaxel 1Cisplatin 1Calcium Dobesilate 1Bupivacaine 1Albumin-Bound Paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Neuralgia × Vincristine × Clear all
NCT00659269 2016-02-26

A Randomized Phase III Study of Vitamins B6 and B12 to Prevent Chemotherapy-Induced Neuropathy in Cancer Patients

New Mexico Cancer Research Alliance

Phase 3 Completed
319 enrolled 7 charts

Neoplasms, Neuralgia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡